These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26639241)

  • 1. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
    Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
    Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma.
    Zhao K; Zhao Y; Zhu JY; Dong H; Cong WM; Yu Y; Wang H; Zhu ZZ; Xu Q
    Curr Med Sci; 2018 Aug; 38(4):590-596. PubMed ID: 30128866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.
    Wang D; Zhu ZZ; Jiang H; Zhu J; Cong WM; Wen BJ; He SQ; Liu SF
    Hepatol Int; 2015 Jul; 9(3):438-46. PubMed ID: 26067772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Copy number aberrations of genes related to extrohepatic metastasis-free survival after operation for hepatocellular carcinoma].
    Bao LL; Zhu ZZ; Wen BJ; Wan XX; Ye YQ; Chen L; He SQ; Cong WM
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):349-353. PubMed ID: 28763841
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinoma.
    Peng G; Chai H; Ji W; Lu Y; Wu S; Zhao H; Li P; Hu Q
    BMC Med Genomics; 2021 Jun; 14(1):150. PubMed ID: 34103027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-related differences in DNA copy number alterations in hepatitis B virus-associated hepatocellular carcinoma.
    Zhu ZZ; Wang D; Cong WM; Jiang H; Yu Y; Wen BJ; Dong H; Zhang X; Liu SF; Wang AZ; Zhu G; Hou L
    Asian Pac J Cancer Prev; 2012; 13(1):225-9. PubMed ID: 22502674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
    Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
    DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma.
    Zhu ZZ; Bao LL; Zhao K; Xu Q; Zhu JY; Zhu KX; Wen BJ; Ye YQ; Wan XX; Wang LL; He SQ; Cong WM
    Curr Med Sci; 2019 Oct; 39(5):759-765. PubMed ID: 31612394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
    Chen CF; Hsu EC; Lin KT; Tu PH; Chang HW; Lin CH; Chen YJ; Gu DL; Lin CH; Wu JY; Chen YT; Hsu MT; Jou YS
    Hepatology; 2010 Nov; 52(5):1690-701. PubMed ID: 20799341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
    Sun S; Li Y; Han S; Jia H; Li X; Li X
    BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA.
    Pang Y; Guo W; Wang J; Xu G; Cheng K; Cao G; Wu M; Cheng S; Liu S
    Oncotarget; 2016 Feb; 7(7):8006-18. PubMed ID: 26769853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.
    Tsuda H; Zhang WD; Shimosato Y; Yokota J; Terada M; Sugimura T; Miyamura T; Hirohashi S
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6791-4. PubMed ID: 2168560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
    Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
    Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
    Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
    BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
    Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
    Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.
    Kusano N; Shiraishi K; Kubo K; Oga A; Okita K; Sasaki K
    Hepatology; 1999 Jun; 29(6):1858-62. PubMed ID: 10347130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.